20-3228684-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM1PM5PP3_StrongPP5_ModerateBS2_Supporting
The NM_001174089.2(SLC4A11):c.2216G>A(p.Arg739Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000548 in 1,460,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R739W) has been classified as Pathogenic.
Frequency
Consequence
NM_001174089.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC4A11 | NM_001174089.2 | c.2216G>A | p.Arg739Gln | missense_variant | 18/20 | ENST00000642402.1 | NP_001167560.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC4A11 | ENST00000642402.1 | c.2216G>A | p.Arg739Gln | missense_variant | 18/20 | NM_001174089.2 | ENSP00000493503.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249138Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135230
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460644Hom.: 0 Cov.: 43 AF XY: 0.00000688 AC XY: 5AN XY: 726646
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 17, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg755 amino acid residue in SLC4A11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17397048, 17679935, 18474783, 22072594). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Experimental studies have shown that this missense change affects SLC4A11 function (PMID: 16767101). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC4A11 protein function. ClinVar contains an entry for this variant (Variation ID: 1304). This missense change has been observed in individuals with congenital hereditary endothelial dystrophy (PMID: 16767101). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs121909387, gnomAD 0.003%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 755 of the SLC4A11 protein (p.Arg755Gln). - |
Congenital hereditary endothelial dystrophy of cornea Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2008 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at